Literature DB >> 3632000

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.

J Revuz, D Penso, J C Roujeau, J C Guillaume, C R Payne, J Wechsler, R Touraine.   

Abstract

Eighty-seven patients with toxic epidermal necrolysis were observed at Hôpital Henri Mondor in Créteil, France, over the last 12 years. The mean percentage of body surface area involved was 39%. Erosive mucous membrane lesions, identical to those of Stevens-Johnson syndrome, were present in all but three cases. Necrolysis was sometimes generalized within 24 hours but usually spread progressively after a Stevens-Johnson syndrome-like aspect at the onset. Mortality was 25%. Infection, mainly with Staphylococus aureus and Pseudomonas aeruginosa, was the first cause of death, clearly responsible in ten of 20 cases. Age, extension of necrolysis, idiopathic nature of toxic epidermal necrolysis, ingestion of many drugs, elevation of urea, creatinine, and glucose levels, neutropenia, lymphopenia, and thrombocytopenia were statistically linked to a bad prognosis. A multivariant analysis showed that three of these prognosis factors are of paramount importance, namely: age, area of necrolysis, and serum urea level. Pigmentary changes and sicca syndrome were frequently observed sequelae in survivors.

Entities:  

Mesh:

Year:  1987        PMID: 3632000     DOI: 10.1001/archderm.123.9.1160

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  64 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

2.  Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.

Authors:  Christos S Zipitis; Nandu Thalange
Journal:  Eur J Pediatr       Date:  2006-09-29       Impact factor: 3.183

Review 3.  Medicine in the elderly.

Authors:  P Diggory; A Homer; J Liddle; C F Pratt; S Samadian; R Tozer; C Weinstein
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

4.  Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Authors:  Chuang-Wei Wang; Lan-Yan Yang; Chun-Bing Chen; Hsin-Chun Ho; Shuen-Iu Hung; Chih-Hsun Yang; Chee-Jen Chang; Shih-Chi Su; Rosaline Chung-Yee Hui; See-Wen Chin; Li-Fang Huang; Yang Yu-Wei Lin; Wei-Yang Chang; Wen-Lang Fan; Chin-Yi Yang; Ji-Chen Ho; Ya-Ching Chang; Chun-Wei Lu; Wen-Hung Chung
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

5.  60-year-old man with rash.

Authors:  Devin E Shahverdian; Constantinos P Anastassiades; Joseph C Charles
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

Review 6.  Drug reactions with eosinophilia and systemic symptoms.

Authors:  B Scrace; A Fityan; C Bigham
Journal:  BJA Educ       Date:  2020-01-08

7.  Ileal involvement in toxic epidermal necrolysis (Lyell syndrome).

Authors:  P Michel; P Joly; P Ducrotte; J Hemet; I Leblanc; P Lauret; E Lerebours; R Colin
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

8.  Does hypernatremia impact mortality in Toxic Epidermal Necrolysis?

Authors:  Thomas Namdar; Tobias von Wild; Frank Siemers; Peter L Stollwerck; Felix H Stang; Peter Mailänder; Thomas Lange
Journal:  Ger Med Sci       Date:  2010-11-02

9.  Drug induced toxic epidermal necrolysis: two case reports.

Authors:  Syed Nurul Rasool Qadir; Naeem Raza; Fozi Qadir
Journal:  Cases J       Date:  2009-09-09

10.  Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case report.

Authors:  Mohamed El Ghonemi; Hesham R Omar; Rania Rashad; Jaya Kolla; Devanand Mangar; Enrico Camporesi
Journal:  Cases J       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.